Literature DB >> 10349771

[Ocular complications of hormonal treatments: oral contraception and menopausal hormonal replacement therapy].

A Glacet-Bernard1, D Kuhn, G Soubrane.   

Abstract

Numerous reports have described ocular complications of sex hormone preparations, particularly after the appearance of the oral contraceptive pill. The most serious complications are vascular occlusions such as central retinal vein or artery occlusion and acute ischemic optic neuropathy. In these cases, permanent visual loss may occur. Combined oral contraceptives have been reported to increase the incidence of these complications but it remains very low. It seems to lessen with the decrease in the estrogen dosage and the use of third-generation progestins. Conversely, post-menopausal hormone replacement therapy seems to have a protective effect for retinal vascular complications. Other ocular involvements have been described with sex hormone preparations but remain not yet confirmed, such as the effect on cataract, lacrymal secretion, diabetic retinopathy, age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10349771

Source DB:  PubMed          Journal:  Contracept Fertil Sex        ISSN: 1165-1083


  2 in total

1.  Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female.

Authors:  Hassan Al-Dhibi; Imtiaz A Chaudhry; Annoud Al-Saati; Farrukh A Shamsi
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

Review 2.  The impact of combined oral contraceptives on ocular tissues: a review of ocular effects.

Authors:  Marilita M Moschos; Eirini Nitoda
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.